Skip to main content
Clinical Trials/NCT00472121
NCT00472121
Completed
Not Applicable

The Precision and Arm-to-Arm Variation og Mechanomyography and Acceleromyography for Monitoring the Neuromuscular Block During Anesthesia, A Randomized Controlled Study

Rigshospitalet, Denmark1 site in 1 countryMay 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neuromuscular Blockade
Sponsor
Rigshospitalet, Denmark
Locations
1
Primary Endpoint
Precision at the contralateral arms using the average residual coefficient of variation over subsequent linear regressions (detrending) over time
Status
Completed
Last Updated
18 years ago

Overview

Brief Summary

The purpose of the study is the examine the precision of acceleromyography and mechanomyography during recovery from a neuromuscular blocking agent and to examine whether there is any difference in monitoring block at the dominant or non-dominant arm. Our hypothesis is that there is no significant difference in neither the precision nor the level of block in the contralateral arms.

Registry
clinicaltrials.gov
Start Date
May 2007
End Date
October 2007
Last Updated
18 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ASA I-III
  • General anesthesia \>1 hour
  • Surgery in supine position w. possibility of monitoring the neuromuscular block at both arms (n. ulnaris stimulation/thumb response)
  • Written informed content

Exclusion Criteria

  • Neuromuscular disorders, hepatic and renal dysfunction
  • Medication expected to interfere with the neuromuscular blocking agent
  • Allergy to any medication used during anaesthesia
  • Body weight less or exceeding 20% of ideal body weight
  • Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Precision at the contralateral arms using the average residual coefficient of variation over subsequent linear regressions (detrending) over time

Secondary Outcomes

  • Bias and limits of agreement between control TOF, reappearance of T1, T2, T3, T4
  • Time to TOF 0.9 and 1.0 with and without normalization
  • Time to stable T1 and stable TOF
  • T1 height at reappearance of T1-T4
  • Interval 25-75%
  • Time to T1=25%

Study Sites (1)

Loading locations...

Similar Trials